Prodesse Seeks FDA OK for New Flu Assay | GenomeWeb

NEW YORK (GenomeWeb News) – Prodesse today said that it has filed for US Food and Drug Administration 510(k) clearance of its ProParaflu+ assay.

The RT-PCR assay has been developed to rapidly detect and differentiate parainfluenza viruses 1, 2 and 3. The Milwaukee, Wis.-based firm said that the new assay is its third respiratory and fourth overall real-time assay that has been submitted for FDA clearance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.